Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Forte

Showing results (161-170 of 163) with videos related to

Pageof 17
Sort By:
You have reached the last page of results.This site can display upto 163 results.
Cancer Research|October 4, 2000
Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMPK Shailubhai, H H Yu, K Karunanandaa, et al.
Kidney International|December 17, 2003
Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptorStephen L Carrithers, Cobern E Ott, Michael J Hill, et al.
European Heart Journal|December 18, 2025
Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEOMINDSET trialCaio A M Tavares, Patricia O Guimarães, Marcelo Franken, et al.
Pageof 17

Showing results (161-170 of 163) with videos related to

Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 163 results.
Cancer Research|October 4, 2000
Uroguanylin treatment suppresses polyp formation in the Apc(Min/+) mouse and induces apoptosis in human colon adenocarcinoma cells via cyclic GMPK Shailubhai, H H Yu, K Karunanandaa, et al.
Kidney International|December 17, 2003
Guanylin and uroguanylin induce natriuresis in mice lacking guanylyl cyclase-C receptorStephen L Carrithers, Cobern E Ott, Michael J Hill, et al.
European Heart Journal|December 18, 2025
Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEOMINDSET trialCaio A M Tavares, Patricia O Guimarães, Marcelo Franken, et al.
Pageof 17